Association of the Low E' and High E/e' with Long-term Outcomes in Patients with Normal Ejection Fraction: a Hospital Population-based Observational Cohort Study
Overview
Authors
Affiliations
Objective: We aimed to evaluate the association of the severity of left ventricular (LV) diastolic dysfunction with long-term outcomes in patients with normal ejection fraction.
Design: Retrospective study.
Setting: A single centre in Japan.
Participants: We included 3576 patients who underwent both scheduled transthoracic echocardiography and ECG between 1 January and 31 December 2013, in a hospital-based population after excluding valvular diseases or low ejection fraction (<50%) or atrial fibrillation and categorised them into three groups: septal tissue Doppler early diastolic mitral annular velocity (e')≥7 (without relaxation disorder, n=1593), e'<7 and early mitral inflow velocity (E)/e'≤14 (with relaxation disorder and normal LV end-diastolic pressure, n=1337) and e'<7 and E/e'>14 (with relaxation disorder and high LV end-diastolic pressure, n=646).
Primary And Secondary Outcome Measures: The primary outcome measure was a composite of all-cause death and major adverse cardiac events (MACE). The secondary outcome measure were all-cause death and MACE, separately.
Results: The cumulative 3-year incidences of the primary outcome measures were significantly higher in the e'<7 and E/e'≤14 (19.0%) and e'<7 and E/e'>14 group (23.4%) than those for the e'≥7 group (13.0%; p<0.001). After adjusting for confounders, the excess 3-year risk of primary outcome for the groups with e'<7 and E/e'≤14 related to e'≥7 (HR: 1.24; 95% CI 1.02 to 1.52) and e'<7 and E/e'>14 related to e'<7 (HR: 1.57; 95% CI 1.28 to 1.94) were significant. The severity of diastolic dysfunction was associated with incrementally higher risk for primary outcomes (p<0.001).
Conclusion: The severity of LV diastolic dysfunction using e'<7 and E/e'>14 was associated with the long-term prognosis in patients with normal ejection fraction in an incremental fashion.
Vermersch E, Neuvendel S, Jouve C, Ruiz-Velasco A, Pereira C, Seguret M JCI Insight. 2024; 9(3).
PMID: 38165745 PMC: 11143964. DOI: 10.1172/jci.insight.161356.
Prognosis value of EAS index in patients with obstructive coronary artery disease.
Kong B, Hu L, Liu Q, Jiang C, Liu Y, Liu A Quant Imaging Med Surg. 2023; 13(9):5877-5886.
PMID: 37711799 PMC: 10498236. DOI: 10.21037/qims-23-109.
Seko Y, Kato T, Yamaji Y, Haruna Y, Nakane E, Haruna T Open Heart. 2021; 8(2).
PMID: 34556560 PMC: 8461736. DOI: 10.1136/openhrt-2021-001765.
Fernandes L, Barreto A, Gomes Neto M, Camara E, Duraes A, Roever L Clinics (Sao Paulo). 2021; 76:e2754.
PMID: 34190849 PMC: 8221562. DOI: 10.6061/clinics/2021/e2754.
Seko Y, Kato T, Yamaji Y, Haruna Y, Nakane E, Haruna T Sci Rep. 2021; 11(1):8892.
PMID: 33903653 PMC: 8076182. DOI: 10.1038/s41598-021-88259-8.